Avvisa Prohibits the Sale of Irregular Insulin and Tirzepatide
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.13 Articles
13 Articles
Rmcarvalho/Getty Images The National Agency for Health Surveillance (Anvisa) banned the marketing of insulin glargine distributed irregularly and determined the seizure of six products sold over the internet as peptides and medicines.The measures were published on Tuesday (6/10) and involve products without sanitary regularization in Brazil.In the case of insulin, the prohibition applies to all lots of glargine of 3 mL/100 IU distributed by the …
Portal Manaus Alerta
The National Agency of Health Surveillance (Anvisa) banned the sale and use of all lots of insulin produced by the company Costa Mar Comércio Licitatorio. The decision was published on Tuesday (6) in the Official Journal of the Union. In a note, Anvisa informed that the company distributed insulin glargina 3 mL/100 IU without authorisation [...] Read more in Anvisa forbids sale of insulin and irregular tirzepatida - Portal Manaus Alerta.
After identifying irregularities, Anvisa prohibits medicines and products sold without registration or authorisation, including insulin and tirzepatide The post Anvisa prohibits insulin, tirzepatide and other products sold irregularly; see what enters the list apareceu primeiro em ND More
In a note, Anvisa informed that the company distributed insulin glargina 3 mL/100 IU without the Company Operating Authorization (AFE) for the activity, in disagreement with the current health legislation.
Open the article to view the coverage from A TARDE
The National Agency of Health Surveillance (Anvisa) banned the sale and use of all lots of insulin produced by the company Costa Mar Comércio Licitório.The decision was published on Tuesday (6) in the Official Journal of the Union.In a note, Anvisa informed that the company distributed insulin glargina 3 mL/100 IU without the Company Operating Authorization (AFE) for the activity, in disagreement with the existing health legislation.Inspection c…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
